The preventive effects of heparin - Superoxide dismutase on carbon tetrachloride-induced acute liver failure and hepatic fibrosis in mice

Molecular and Cellular Biochemistry

Volumn 327, Issue 1-2, 2009, Pages 219-228

  Liu, Jinfeng ^a   Tan, Haining ^a   Sun, Yongfu ^a   Zhou, Shuai ^a   Cao, Jichao ^a   Wang, Fengshan ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Acute liver failure; Cu, Zn superoxide dismutase; Heparin SOD; Hepatic fibrosis; Hydroxyproline

Indexed keywords

ANIMALS; CARBON TETRACHLORIDE; COLLAGENASES; HEPARIN; LIVER CIRRHOSIS; LIVER FAILURE, ACUTE; MALE; MATRIX METALLOPROTEINASE 2; MICE; RNA, MESSENGER; SUPEROXIDE DISMUTASE; TRANSFORMING GROWTH FACTOR BETA1;

MUS;

EID: 67349241425     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-009-0060-2     Document Type: Article

References (52)

1. Halliwell B, Gutteridge JM (1990) Role of free radicals and catalytic metal ions in human diseases: An overview. Methods Enzymol 186:1-85. doi: 10.1016/0076-6879(90)86093-B
2. Cerutti PA (1991) Oxidant stress and carcinogenesis. Eur J Clin Invest 21:1-5. doi: 10.1111/j.1365-2362.1991.tb01350.x
3. Keating DJ (2008) Mitochondrial dysfunction, oxidative stress, regulation of exocytosis and their relevance to neurodegenerative diseases. J Neurochem 104:298-305
4. Halliwell B (1996) Free radicals, proteins and DNA: Oxidative damage versus redox regulation. Biochem Soc Trans 24:1023-1027
5. Bellocq A, Azoulay E, Marullo S et al (1999) Reactive oxygen and nitrogen intermediates increase transforming growth factor beta 1 release from human epithelial alveolar cells through two different mechanisms. Am J Respir Cell Mol Biol 21:128-136
6. Hagimoto N, Kuwano K, Inoshima I et al (2002) TGF-beta 1 as an enhancer of Fas-mediated apoptosis of lung epithelial cells. J Immunol 168:6470-6478
7. Greenwald RA (1990) Superoxide dismutase and catalase as therapeutic agents for human diseases: A critical review. Free Radic Biol Med 8:201-209. doi: 10.1016/0891-5849(90)90092-W
8. Vozenin-Brotons MC, Sivan V, Gault N et al (2001) Antifibrotic action of Cu/Zn SOD is mediated by TGF-beta 1 repression and phenotypic reversion of myofibroblasts. Free Radic Biol Med 30:30-42. doi: 10.1016/ S0891-5849(00)00431-7
9. McCord JM, Edeas MA (2005) SOD, oxidative stress and human pathologies: a brief history and a future vision. Biomed Pharmacother 59:139-142. doi: 10.1016/j.biopha.2005.03.005
10. Suzuki Y, Matsumoto T, Okamoto S et al (2008) A lecithinized superoxide dismutase (PC-SOD) improves ulcerative colitis. Colorectal Dis 10:931-934
11. Suzuki J, Broeyer F, Cohen A et al (2008) Pharmacokinetics of PC-SOD, a lecithinized recombinant superoxide dismutase, after single- and multiple-dose administration to healthy Japanese and Caucasian volunteers. J Clin Pharmacol 48:184-192. doi: 10.1177/0091270007309705
12. Tsubokawa T, Jadhav V, Solaroglu I et al (2007) Lecithinized superoxide dismutase improves outcomes and attenuates focal cerebral ischemic injury via antiapoptotic mechanisms in rats. Stroke 38:1057-1062. doi: 10.1161/01.STR.0000257978.70312.1d
13. Geller RL, Ihrcke NS, Maines J et al (1993) Loss of heparan sulfate proteoglycans as a manifestation of cellular immunity in vivo and in vitro. Transplant Proc 25:144-145
14. Grant D, Long WF, Williamson FB (1987) Pericellular heparans may contribute to the protection of cells from free radicals. Med Hypotheses 23:67-71. doi: 10.1016/0306-9877(87)90183-6
15. Tyagi SC, Kumar S, Katwa L (1997) Differential regulation of extracellular matrix metalloproteinase and tissue inhibitor by heparin and cholesterol in fibroblast cells. J Mol Cell Cardiol 29:391-404. doi: 10.1006/jmcc.1996.0283
16. El Nabout R, Martin M, Remy J et al (1989) Heparin fragments modulate the collagen phenotype of fibroblasts from radiation-induced subcutaneous fibrosis. Exp Mol Pathol 51:111-122. doi: 10.1016/ 0014-4800(89)90012-9
17. Castellot JJ, Wong K, Herman B et al (1985) Binding and internalization of heparin by vascular smooth muscle cells. J Cell Physiol 124:13-20. doi: 10.1002/jcp.1041240104
18. Adachi T, Hara H, Yamada H et al (2001) Heparin-stimulated expression of extracellular-superoxide dismutase in human fibroblasts. Atherosclerosis 159:307-312. doi: 10.1016/S0021-9150(01)00512-3
19. Weigert C, Brodbeck K, Haring HU et al (2001) Low-molecular-weight heparin prevents high glucose- and phorbol ester-induced TGF-beta 1 gene activation. Kidney Int 60:935-943. doi: 10.1046/ j.1523-1755.2001.060003935.x
20. Pecly IM, Goncalves RG, Rangel EP et al (2006) Effects of low molecular weight heparin in obstructed kidneys: Decrease of collagen, fibronectin and TGF beta, and increase of chondroitin/dermatan sulfate proteoglycans and macrophage infiltration. Nephrol Dial Transplant 21:1212-1222. doi: 10.1093/ndt/gfk076
21. Penttinen RP, Kobayashi S, Bornstein P (1988) Transforming growth factor beta increases mRNA for matrix proteins both in the presence and in the absence of changes in mRNA stability. Proc Natl Acad Sci USA 85:1105-1108. doi: 10.1073/pnas.85.4.1105
22. Qi JZ, Wang FS, Zhang HW et al (2006) Chemical modification of superoxide dismutase by low molecular weight heparin and their physical and chemical properties. Chin Pharm J 41:150-153
23. Zhang HW, Wang FS, Shao W et al (2006) Characterization and stability investigation of Cu, Zn-superoxide dismutase covalently modified by low molecular weight heparin. Biochemistry (Mosc) 71:S96-S100. doi: 10.1134/ S0006297906130165
24. Liu JF, Wang X, Wang FS et al (2008) Attenuation effects of heparin-superoxide dismutase conjugate on bleomycin-induced lung fibrosis in vivo and radiation-induced inflammatory cytokine expression in vitro. Biomed Pharmacother. doi: 10.1016/j.biopha.2008.04.009
25. 4-induced liver fibrosis. Biochem Biophys Res Commun 346:658-664. doi: 10.1016/ j.bbrc.2006.05.183
26. Zhang S, Ji G, Liu J (2006) Reversal of chemical-induced liver fibrosis in Wistar rats by puerarin. J Nutr Biochem 17:485-491. doi: 10.1016/ j.jnutbio.2005.09.002
27. Habeeb AF (1966) Determination of free amino groups in proteins by trinitrobenzenesulfonic acid. Anal Biochem 14:328-336. doi: 10.1016/ 0003-2697(66)90275-2
28. Ma SF, Nishikawa M, Katsumi H et al (2006) Liver targeting of catalase by cationization for prevention of acute liver failure in mice. J Control Release 110:273-282. doi: 10.1016/j.jconrel.2005.10.016
29. Brunt EM (2000) Grading and staging the histopathological lesions of chronic hepatitis: The Knodell histology activity index and beyond. Hepatology 31:241-246. doi: 10.1002/hep.510310136
30. Zhen MC, Wang Q, Huang XH et al (2007) Green tea polyphenol epigallocatechin-3-gallate inhibits oxidative damage and preventive effects on carbon tetrachloride-induced hepatic fibrosis. J Nutr Biochem 18:795-805. doi: 10.1016/j.jnutbio.2006.12.016
31. Ma SF, Nishikawa M, Katsumi H et al (2006) Liver targeting of catalase by cationization for prevention of acute liver failure in mice. J Control Release 110:273-282. doi: 10.1016/j.jconrel.2005.10.016
32. Parola M, Robino G (2001) Oxidative stress-related molecules and liver fibrosis. J Hepatol 35:297-306. doi: 10.1016/S0168-8278(01)00142-8
33. Slater TF, Cheeseman KH, Ingold KU (1985) Carbon tetrachloride toxicity as a model for studying free-radical mediated liver injury. Philos Trans R Soc Lond B Biol Sci 311:633-645. doi: 10.1098/rstb.1985.0169
34. Tsukamoto H, Matsuoka M, French SW (1990) Experimental models of hepatic fibrosis: A review. Semin Liver Dis 10:56-65. doi: 10.1055/s-2008-1040457
35. 4-induced liver fibrosis in rats. Food Chem Toxicol 44:336-343. doi: 10.1016/j.fct.2005.08.003
36. Fujita T, Nishikawa M, Tamaki C et al (1992) Targeted delivery of human recombinant superoxide dismutase by chemical modification with mono- and polysaccharide derivatives. J Pharmacol Exp Ther 263:971-978
37. Fujita T, Furitsu H, Nishikawa M et al (1992) Therapeutic effects of superoxide dismutase derivatives modified with mono- or polysaccharides on hepatic injury induced by ischemia/reperfusion. Biochem Biophys Res Commun 189:191-196. doi: 10.1016/0006-291X(92)91543-Y
38. Bussey H, Francis JL (2004) Heparin overview and issues. Pharmacotherapy 24:103S-107S. doi: 10.1592/phco.24.12.103S.36109
39. Tyrrell DJ, Horne AP, Holme KR et al (1999) Heparin in inflammation: potential therapeutic applications beyond anticoagulation. Adv Pharmacol 46:151-208. doi: 10.1016/S1054-3589(08)60471-8
40. Rose MJ, Page C (2004) Glycosaminoglycans and the regulation of allergic inflammation. Curr Drug Targets Inflamm Allergy 3:221-225. doi: 10.2174/ 1568010043343589
41. Bobek V, Kovarik J (2004) Antitumor and antimetastatic effect of warfarin and heparins. Biomed Pharmacother 58:213-219. doi: 10.1016/ j.biopha.2003.11.007
42. Linhardt RJ (2004) Heparin-induced cancer cell death. Chem Biol 11:420-422. doi: 10.1016/j.chembiol.2004.04.001
43. Castellot JJ Jr, Pukac LA, Caleb BL et al (1989) Heparin selectively inhibits a protein kinase C-dependent mechanism of cell cycle progression in calf aortic smooth muscle cells. J Cell Biol 109:3147-3155. doi: 10.1083/jcb.109.6.3147
44. Okona-Mensah KB, Shittu E, Page C et al (1998) Inhibition of serum and transforming growth factor beta (TGF-beta 1)-induced DNA synthesis in confluent airway smooth muscle by heparin. Br J Pharmacol 125:599-606. doi: 10.1038/sj.bjp.0702046
45. Lankes W, Griesmacher A, Grüwald J et al (1988) A heparin-binding protein involved in inhibition of smooth-muscle cell proliferation. Biochem J 251:831-842
46. 60 gamma-rays. Radiat Environ Biophys 22:281-291. doi: 10.1007/BF01323678
47. Ookhtens M, Kaplowitz N (1998) Role of the liver in interorgan homeostasis of glutathione and cyst(e)ine. Semin Liver Dis 18:313-329. doi: 10.1055/s-2007-1007167
48. Zhang ZG, Zhang QZ, Cheng YN et al (2007) Antagonistic effects of ultra-low-molecular-weight heparin against cerebral ischemia/reperfusion injury in rats. Pharmacol Res 56:350-355. doi: 10.1016/j.phrs.2007.08.004
49. Abe W, Ikejima K, Lang T et al (2007) Low molecular weight heparin prevents hepatic fibrogenesis caused by carbon tetrachloride in the rat. Abe J Hepatol 46:286-294. doi: 10.1016/j.jhep.2006.08.023
50. Preaux AM, Mallat A, Nhieu JT et al (1999) Matrix metalloproteinase-2 activation in human hepatic fibrosis by cell-matrix interaction. Hepatology 30:944-950. doi: 10.1002/hep.510300432
51. Benyon RC, Arthur MJ (2001) Extracellular matrix degradation and the role of hepatic stellate cells. Semin Liver Dis 21:373-384. doi: 10.1055/ s-2001-17552
52. Gaca MD, Zhou X, Issa R et al (2003) Basement membrane-like matrix inhibits proliferation and collagen synthesis by activated rat hepatic stellate cells: Evidence for matrix-dependent deactivation of stellate cells. Matrix Biol 22:229-239. doi: 10.1016/S0945-053X(03)00017-9